Freenome - Crunchbase Company Profile & Funding

Q: Who invested in Freenome?

Freenome has 56 investors including Roche And Exact Sciences.

Q: When was the last funding round for Freenome?

Freenome closed its last funding round on obfuscated from a Corporate Round round.

Q: How much funding has Freenome raised to date?

Freenome has raised obfuscated.

Overview

Freenome

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Freenome

CB Rank

970

Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.

Acquired by

Perceptive Capital Solutions

Founded

obfuscation

Private

Corporate Round

South San Francisco, California, United States

251-500

www.freenome.com

Biotechnology

Health Care

Health Diagnostics

Oncology

Personal Health

Funding Rounds

Corporate Round

OBF

obfuscation

Corporate Round

OBF

obfuscation

Convertible Note

OBF

obfuscation

Key People

Riley Ennis: Co-Founder and COO
Girish Putcha: Chief Medical Officer
Past Role: Panorama Capital, Life Sciences Team

Details

Legal Name

Freenome Inc.

Operating Status

Active

Company Type

For Profit

Founders

Charles Roberts, Gabriel Otte, Michael Otte, Riley Ennis

About the Company

Freenome is a private biotech company that focuses on developing blood tests for early cancer detection, aiming to make screening accessible to everyone. The company aims to empower individuals in cancer prevention, detection, and treatment through innovative, non-invasive testing solutions. The company is at the forefront of non-invasive disease

screening, which could transform how cancers and other diseases are proactively managed.

Contact Email

press@freenome.com

Hub Tags

Unicorn

Predictions & Insights

Growth Insight

See this Growth Insight

Freenome is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Freenome Multiomics Platform

A platform that uses multiomics technology and machine learning to detect early-stage cancer from a routine blood draw.

Blood-Based Colorectal Cancer Screening Test

A blood test developed to detect colorectal cancer early using biomarkers identified by the multiomics platform.

Research & Development

Freenome is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round
obfuscated obfuscation	Corporate Round - Freenome	1	obfuscated obfuscation	Roche	Corporate Round

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Roche	Yes	Corporate Round - Freenome	—
Roche	Yes	Corporate Round - Freenome	—
Roche	Yes	Corporate Round - Freenome	—
Roche	Yes	Corporate Round - Freenome	—
Roche	Yes	Corporate Round - Freenome	—